BioCODE Technologies (Pty) Ltd

BioCODE is working toward a future where the cure lies in prevention. We develop point-of-care smart sensing solutions that detect novel circulating inflammatory molecules in the blood. These molecules are present during the very early stages of disease.

More than 70% of deaths worldwide are caused by non-communicable diseases such as cancer, cardiovascular and neuro-degenerative diseases. It’s a modern pandemic with a common underlying factor – inflammation. Chronic systemic inflammation is not only linked to  the progression of disease but also to the onset. It can wage a subtle war on the body long before before the manifestation of disease.  

Medical professionals using our sensing technology will be able to identify disease risk, monitor patients and determine compliance to treatment regimes.

Visit BioCODE website for more information here.